Cargando…
EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression
Metastasis is the primary cause of prostate cancer (CaP)-related death. We investigate the molecular, pathologic and clinical outcome associations of EphA6 expression and CaP metastasis. The expression profiling of Eph receptors (Ephs) and their ephrin ligands was performed in parental and metastati...
Autores principales: | Li, Shibao, Ma, Yingyu, Xie, Chongwei, Wu, Zhiyuan, Kang, Zhihua, Fang, Zujun, Su, Bing, Guan, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673184/ https://www.ncbi.nlm.nih.gov/pubmed/26041887 |
Ejemplares similares
-
Downregulation of EphA5 by promoter methylation in human prostate cancer
por: Li, Shibao, et al.
Publicado: (2015) -
Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression
por: Li, Shibao, et al.
Publicado: (2017) -
The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy
por: Duan, Xiuzhi, et al.
Publicado: (2019) -
EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016) -
Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K
por: Wang, Hua, et al.
Publicado: (2016)